Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Metso Outotec establishes a Euro Medium Term Note programme

Metso Outotec Corporation’s press release on November 13, 2020, at 6:15 p.m. EETMetso Outotec Corporation has established a EUR 2,000,000,000 Euro Medium Term Note (“EMTN”) programme. The Luxembourg Commission de Surveillance du Secteur Financier has approved the base prospectus for the programme on 13 November 2020, which will be available on the website of Luxembourg Stock Exchange at www.bourse.lu/issuer/MetsoOut/100755 and on Metso Outotec’s website at www.mogroup.com/investors/reports-and-presentations. Metso Outotec has mandated Citigroup Global Market Limited to act as an arranger

NRC Group ASA - Appointed to a contract in Norway - NOK 220 million

Bane NOR has appointed NRC Bane AS, a company wholly owned by NRC Group ASA, to a contract for the rehabilitation and upgrading of Nittedal railway station. The project will increase the quality and track capacity to ensure long-term reliability on Gjørvikbanen. The contract is valued at approximately NOK 220 million and will involve rail services such as groundwork, track, electro and signal/telecom. The work will commence in December 2020, and the project is scheduled for completion in August 2022. Closing date for submission of complaints is 10 days from today, and formal

Dignitana publishes November newsletter

Dignitana AB today publishes the November 2020 newsletter highlighting the recent announcement from the American Medical Association of a CPT® code that will be issued in 2021. To read the newsletter click here. The Dignitana InBrief newsletter is published monthly and posted at www.dignitana.se as part of Dignitana's commitment to provide ongoing communication to the market. To subscribe to receive future Dignitana news directly to your email, click here .

Scandion Oncology – Minutes of extraordinary general meeting

which was held on: Friday 13 November 2020, at 2.00 PM at Scandion Oncology A/S’ (the “Company”) office at Fruebjergvej 3, 2100 Copenhagen Ø, Denmark. Due to COVID-19 it was also possible to attend the general meeting using Microsoft Teams as set out in the notice.Agenda 1. Election of chairman of the meeting. 2. Proposal to authorize the Board of Directors to increase the Company’sshare capital with pre-emptive rights. 3. Information on final allocation of warrants. 4. Approval of authorization of the Chairman of the meeting. Re 1   Election of chairman

Castellum acquires real estate group in Helsinki

Through a company acquisition of the Finnish real estate group Lindström Invest, Castellum has acquired a real estate portfolio in Helsinki. The transaction is carried out as a share issue in kind.The portfolio comprises five office properties with a total lettable area of approximately 36,000 sq.m. The acquisition price amounts to EUR 150 million, including overheads of EUR 7 million, of which EUR 81 million is paid as a share issue in kind and the remaining consists of takeover of debt. All properties are well located in Kalasatama, a former port area that the City of Helsinki is now

Supplement No. 2 to the offer document regarding Peutinger AB’s mandatory cash offer to the shareholders of Internationella Engelska Skolan made public

THIS PRESS RELEASE IS NOT AN OFFER, WHETHER DIRECTLY OR INDIRECTLY, IN AUSTRALIA, CANADA, HONG KONG, JAPAN, NEW ZEALAND, SOUTH AFRICA OR SWITZERLAND OR IN ANY OTHER JURISDICTION WHERE SUCH OFFER PURSUANT TO LEGISLATION AND REGULATIONS IN SUCH RELEVANT JURISDICTION WOULD BE PROHIBITED BY APPLICABLE LAW. SHAREHOLDERS NOT RESIDENT IN SWEDEN WHO WISH TO ACCEPT THE OFFER (AS DEFINED BELOW) MUST MAKE INQUIRIES CONCERNING APPLICABLE LEGISLATION AND POSSIBLE TAX CONSEQUENCES. SHAREHOLDERS SHOULD REFER TO THE OFFER RESTRICTIONS INCLUDED IN THE SECTION TITLED “IMPORTANT INFORMATION” AT THE END OF THIS

#20-411 Changes to certain Derivatives at NGM

From November 16, 2020, certain derivatives are subject to changes.For more details, see attached file. For further information concerning this NGM notice please contact NGM Listing department on phone +46 8 566 390 20 or listings@ngm.se. Nordic Growth Market NGM AB About NGMNordic Growth Market NGM AB (NGM) is an authorized stock exchange with operations in Sweden, Norway, Denmark and Finland. The exchange is a wholly-owned subsidiary of Boerse Stuttgart, the leading retail exchange in Germany. NGM offers a complete marketplace for exchange traded products and provides a

#20-410 Listing of Derivatives at NGM

Information about various derivatives that will be listed at NGM.For more details, see attached file. For further information concerning this NGM notice please contact NGM Listing department on phone +46 8 566 390 20 or listings@ngm.se. Nordic Growth Market NGM AB About NGMNordic Growth Market NGM AB (NGM) is an authorized stock exchange with operations in Sweden, Norway, Denmark and Finland. The exchange is a wholly-owned subsidiary of Boerse Stuttgart, the leading retail exchange in Germany. NGM offers a complete marketplace for exchange traded products and provides a

Hexagon Composites ASA: Minutes from Extraordinary General Meeting

The extraordinary general meeting of Hexagon Composites ASA was held today, Friday 13 November 2020 in Aalesund, Norway. All proposals on the agenda were adopted, cf. the notice of the extraordinary general meeting that was sent to the Oslo Stock Exchange on 23 October 2020. The complete minutes of the extraordinary general meeting are attached to this release and are also available on www.hexagongroup.com.  For more information: David Bandele, CFO, Hexagon Composites ASATelephone: +47 920 91 483 | david.bandele@hexagongroup.com

Brighter's subsidiary Nectarine Health won the “People’s choice award” at Techarenan Challenge 2020

Brighter's subsidiary Nectarine Health, introducing AI solutions for improved remote care at home, has won the “People’s choice award” at the Techarenan Challenge 2020 - a competition for the Nordic region's most promising companies. The recorded live pitch can be watched in retrospect here . ”We are proud of the Nectarine team which has developed a fantastic solution and are now facing a very exciting year with a broad American launch in sight 2021,” says Henrik Norström, CEO of Brighter. About NectarineNectarine® is an artificial intelligence

Componenta Corporation’s Board of Directors resolved on a rights issue and publishes the terms and conditions of the rights issue

Componenta Corporation, Insider information, 13 November 2020 at 16:35 NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR TO THE UNITED STATES, CANADA, NEW ZEALAND, AUSTRALIA, JAPAN, HONG KONG, SINGAPORE, SOUTH AFRICA OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL. Componenta Corporation (“Componenta” or “Company”) announced on 5 October 2020 plans for a rights issue. Based on authorization granted by the Extraordinary General Meeting of Componenta Corporation held on 29 October 2020, Componenta Corporation’s Board of

Magnolia Bostad sells 180 residential units in Göteborg

Magnolia Bostad is selling 180 rental apartments in the new district of Nya Hovås in Göteborg to Heimstaden Bostad. The project consists of around 11,060 m[2] GFA for residential units and around 2,500 m[2] GFA for retail units and a garage. The estimated property value upon completion will be around SEK 450 million.The sale will take place as a corporate transaction and concerns the property Hovås 451: 67. The project is part of the framework agreement with Heimstaden, which was signed in June 2018, has a zoning plan in force and a turnkey contract has been signed with Consto AB. The

OssDsign’s CFO Claes Lindblad is leaving the company

OssDsign AB (publ) today announces that CFO Claes Lindblad is leaving the company in order to pursue other opportunities.A leading international recruitment firm has been engaged to lead the search process for a new CFO. Anders Svensson, a highly experienced leader with international experience, will take up the position as interim CFO as of Monday November 16, 2020. Anders Svensson has previous experience from amongst other Aura Light and Bluefish Pharmaceuticals. "I am very happy to welcome Anders Svensson as interim CFO. Anders, with his solid experience, will contribute to our

#20-408 No market making in certain instruments issued by Societe Generale Effekten GmbH

Due to technical problems, Societe Generale Effekten GmbH is not able to act as a market maker in certain instruments.These instruments will be in an Order Protection Auction thus preventing any trades being executed until the market maker returns with prices. Market making will be resumed as soon as possible. For further information concerning this NGM notice please contact: NGM market surveillance, +46 8 566 390 55, marketsurveillance@ngm.se Nordic Growth Market NGM AB

Citycon Group successfully places a NOK 800 million Green Bond

CITYCON OYJ Stock Exchange Release 13 November 2020 at 15:45 hrsNOT TO BE RELEASED, PUBLISHED OR DISTRIBUTED, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART IN OR INTO OR TO ANY PERSON LOCATED IN OR RESIDENT IN THE UNITED STATES, ITS TERRITORIES AND POSSESSIONS, ANY STATE OF THE UNITED STATES OR THE DISTRICT OF COLUMBIA (TOGETHER THE "UNITED STATES"), AUSTRALIA, CANADA OR JAPAN OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL. Citycon Group has successfully placed a NOK 800 million green bond (the "Bond"). The issuer of the Bond is Citycon Treasury B.V. and

Wärtsilä is ready to combat the US$1 trillion climate problem with smart technologies

Wärtsilä Corporation, News, 13 November 2020 at 3:30 PM E. Europe Standard TimeGlobal businesses are facing an era of unprecedented disruption and transformation as a direct result of climate change. The financial cost of climate change risk, estimated to be upwards of US$1 trillion, poses a significant threat to businesses. A joint survey of more than 500 directors and C-suite executives from the world’s leading companies, conducted by global legal practice, Eversheds Sutherland, and global professional services organization, KPMG, revealed that company boards and management recognize the

SSAB confirms discussions regarding Tata Steel Europe Netherlands

SSAB confirms that it is in discussions with Tata Steel Group concerning a potential acquisition of Tata Steel Europe’s IJmuiden steel mill and related downstream assets.SSAB has participated in several different discussions concerning consolidations in the European steel industry. The discussions with Tata are on-going but no decisions have been made. There can be no certainty that any transaction will materialize, nor as to the terms of any such potential transaction. Further announcement will be made in due course. For further information, please contact:Investor Relations: Per

Changed time and possibility of advance voting at the annual general meeting in Internationella Engelska Skolan i Sverige Holdings II AB (publ)

In light of the continued spread of Covid-19 and in order to minimise the number of people on Internationella Engelska Skolan in Enskede’s premises, a number of new measures have been resolved on regarding the annual general meeting, including changed time and possibility of advance voting.The time for the annual general meeting in Internationella Engelska Skolan i Sverige Holdings II AB (publ), reg. no. 556900-7254, has been changed. The annual general meeting will take place on Tuesday 24 November at 5pm at Internationella Engelska Skolan in Enskede, Lingvägen 123, Enskede. The board of

A new centre for bioeconomy development test beds

Now work begins with the investment in a world-unique test bed environment for commercialization of new technologies, products and services within bioeconomy. In a first phase, a flexible pilot hall is being built with several different test beds adjacent to RISE already established activities in Örnsköldsvik.In the autumn budget, the Government has allocated RISE SEK 350 million over two years to RISE with the intent to intensify work on sustainable solutions in bioeconomy. The addition will strengthen RISE investment in test beds for biorefinery. Now, the first step is being taken in the

The new shares of NoHo Partners Plc have been registered into the Trade Register and the book-entry system of Euroclear Finland Oy

NoHo Partners Plc STOCK EXCHANGE RELEASE 13 November 2020 at 14:15The new shares of NoHo Partners Plc have been registered into the Trade Register and the book-entry system of Euroclear Finland Oy The Board of Directors of NoHo Partners Plc has on 9 November 2020 resolved on a directed share issue without payment to the key employees of the company in order to pay the reward for the first earning period of the long-term share-based incentive plan from 1 December 2018 to 31 December 2019. The stock exchange release concerning the directed share issue without payment was published on

Visual marketing startup Flowbox selected to take part in Facebook’s new Accelerator Program for Commerce

Swedish user generated content (UGC) platform provider Flowbox has been selected to take part in Facebook’s 12-week Accelerator: Commerce program. Flowbox is one of only 11 European startups invited to participate in the newly launched Facebook Facebook Accelerator: Commerce program. The mentorship program has been introduced for startups in Europe, Latin America, Africa, and the Middle East offering technologically innovative solutions to help enhance the Facebook commercial experience. Flowbox, founded in 2016, provides a platform that enables companies to easily collect, manage and

The CHMP has adopted a negative opinion for emapalumab in Europe for the treatment of primary HLH

Swedish Orphan Biovitrum AB (publ) (Sobi™) (STO:SOBI)  today announced that the Committee for Medicinal Products for Human use (CHMP) has adopted a negative opinion recommending a refusal of the marketing authorisation for emapalumab for the treatment of primary haemophagocytic lymphohistiocytosis (pHLH) in children under 18 years of age in Europe. The negative opinion was given after the re-examination requested by Sobi after the initial opinon in July 2020. “This recommendation by the CHMP is disappointing given the significant unmet medical need which exists for

There are no items matching the current filter
There are no more items matching the current filter
Back to top